Clinical Trials in Chicago

Showing 9721-9740 of 20,493 trials

Treatment for COVID-19 in High-Risk Adult Outpatients

NCT04354428

This is a randomized trial for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in high-risk adults not requiring hospital admission.The overarching goal of this study is to assess the effectiveness of interventions on the incidence of lower respiratory tract infection (LRTI) progression among high-risk adult outpatients with SARS-CoV-2 infection to inform public health control strategies.

COVID-19SARS-CoV-2

University of Washington289 participantsStarted Apr 2020

Chicago, Illinois, United States • New Orleans, Louisiana, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDNA2.2 miles

Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome

NCT00738920

The primary goal of the proposed trial is to assess the short- and long-term efficacy of cognitive behavior therapy (CBT) for irritable bowel syndrome using two treatment delivery systems (self administered, therapist administered). Secondary aims seek to specify the conditions under which CBT may (or may not) achieve its effects (moderator questions), why and how these effects are achieved (mediator questions) and at what economic cost. Long term project goals are to develop an effective self-administered behavioral treatment program that can enhance the quality of patient care, improve clinical outcomes, and decrease the economic and personal costs of one of the most prevalent and intractable GI disorders.

Irritable Bowel Syndrome

State University of New York at Buffalo436 participantsStarted Aug 2010

Chicago, Illinois, United States • Buffalo, New York, United States

Treatment for COVID-19 in High-Risk Adult Outpatients

Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome

Find Trials by Condition in Chicago

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

BRITEPath, Component 3 of iCHART (Integrated Care to Help At-Risk Teens)

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205

Time-Restricted Eating With Exercise